Clinical Trials on TTR-mediated Amyloidosis in Norway
Total 7 results
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States, Poland, Argentina, Australia, Belgium, France, Germany, Japan, Netherlands, Portugal, Spain, Sweden, United Kingdom, Canada, Czechia, Denmark, Hungary, Ireland, Norway, Korea, Republic of, Austria, Croatia, Israel, Latvia, Lithuan... and more
-
Oncopeptides ABPRA Health SciencesTerminatedAL AmyloidosisSpain, United Kingdom, Germany, Norway, Israel, France, United States, Czechia, Greece
-
Alexion PharmaceuticalsTerminatedAntibody Mediated RejectionUnited States, Germany, Italy, France, United Kingdom, Spain, Sweden, Australia, Netherlands, Norway
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Orion Corporation, Orion PharmaCompletedContinuous Sedation in Initially Sedated Adults in ICUNetherlands, Belgium, Estonia, Finland, France, Germany, Norway, Switzerland, United Kingdom
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingNausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary AmyloidosisUnited States
-
Alexion Pharmaceuticals, Inc.RecruitingTransthyretin Amyloid CardiomyopathyUnited States, Spain, United Kingdom, Norway, Israel, Korea, Republic of, Belgium, France, Germany, Italy, Japan, China, Australia, Argentina, Austria, Taiwan, Switzerland, Canada, Sweden, Poland, Denmark, Turkey, Brazil, Netherlands, G... and more